These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17702565)

  • 1. Recombinant factor VIIa should be used in massive obstetric haemorrhage.
    Van de Velde M
    Int J Obstet Anesth; 2007 Oct; 16(4):357-9. PubMed ID: 17702565
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant factor VIIa should be used in massive obstetric haemorrhage.
    Plaat F
    Int J Obstet Anesth; 2007 Oct; 16(4):354-7. PubMed ID: 17698342
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.
    Nicklin J; Perrin L; Crandon A; Land R; Nascimento M; Obermair A
    Aust N Z J Obstet Gynaecol; 2008 Aug; 48(4):447. PubMed ID: 18837857
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant factor VIIa in massive obstetric haemorrhage.
    Bhuskute N; Kritzinger S; Dakin M
    Eur J Anaesthesiol; 2008 Mar; 25(3):250-1. PubMed ID: 18226279
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature.
    Boehlen F; Morales MA; Fontana P; Ricou B; Irion O; de Moerloose P
    BJOG; 2004 Mar; 111(3):284-7. PubMed ID: 14961895
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2007; 25(12):1007-29. PubMed ID: 18047387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
    Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA;
    Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
    Croom KF; McCormack PL
    BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can we still afford progress in intensive care medicine? Re: the article from DMW 1-2/2004].
    Kalenka A
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1698-9; author reply 1699-70. PubMed ID: 15273924
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary embolism after administration of recombinant activated Factor VII for major obstetric hemorrhage.
    McCarthy GC; Allen TK; Habib AS
    J Clin Anesth; 2012 Sep; 24(6):508-9. PubMed ID: 22986324
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
    Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
    Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant factor VIIa and factor VIII treatment for acquired factor VIII deficiency: a case of repeated thrombotic endotracheal occlusion in a mechanically ventilated patient.
    Lauer S; Westphal M; Fischer LG; Meissner A; Van Aken H; Freise H
    Crit Care; 2011; 15(2):407. PubMed ID: 21418550
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.
    Mazer CD; Leong-Poi H; Mahoney J; Latter D; Strauss BH; Teitel JM
    Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):261-4. PubMed ID: 18270189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony].
    Michalska-Krzanowska G
    Ginekol Pol; 2010 Jul; 81(7):544-8. PubMed ID: 20825059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant factor VIIa for major obstetric haemorrhage in a Jehovah's Witness.
    Laird R; Carabine U
    Int J Obstet Anesth; 2008 Apr; 17(2):193-4. PubMed ID: 18308545
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.
    Shamsi TS; Hossain N; Soomro N; Hasan JA; Noorani M; Kazi S; Quraishy MS; Jameel B; Sultan ST; Haider S
    J Pak Med Assoc; 2005 Nov; 55(11):512-5. PubMed ID: 16304877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant activated factor VII in massive obstetric haemorrhage.
    Haynes J; Laffan M; Plaat F
    Int J Obstet Anesth; 2007 Jan; 16(1):40-9. PubMed ID: 17126006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for use of recombinant factor VIIa in life-threatening post-partum haemorrhage.
    Duffy MR
    Int J Obstet Anesth; 2007 Jul; 16(3):299-300; author reply 300. PubMed ID: 17509865
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
    Franchini M; Franchi M; Bergamini V; Salvagno GL; Montagnana M; Lippi G
    Semin Thromb Hemost; 2008 Feb; 34(1):104-12. PubMed ID: 18393147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.